Top Medical News

Trastuzumab Deruxtecan Receives Priority Review for Select Patients With HER2+ Metastatic Breast Cancer

January 18th 2022

A supplemental biologics license application has been granted to trastuzumab deruxtecan-nxki for the treatment of adult patients with select HER2-positive breast cancer.

Cervical Cancer Advances May Heighten Preexisting Health Disparities

January 18th 2022

As the HPV vaccine becomes more prevalent, cervical cancer rates are expected to decrease significantly by 2030. However, this trend may differ across socioeconomic communities.

Young Women With Breast Cancer Who Undergo Mastectomy Report Lower Quality of Life

January 17th 2022

A patient-reported outcome survey highlighted quality-of-life gaps in breast cancer survivorship.

Nurses May Advise Patients on Immunotherapy to Increase Fiber Intake

January 17th 2022

An expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.

Ibrutinib/Rituximab Combo May Be an Effective Chemo-Free Therapy for Older Patients With MCL

January 16th 2022

Ibrutinib plus rituximab is effective, easy to administer, and removes the need for chemotherapy in older patients, say experts.


Most Recent